UK’s MYndspan Partners with MEGIN to Expand Access to High-Precision Brain Scans

Picture Credit | World Wide Web

MYndspan, a pioneer in consumer brain health technology, has announced a partnership with MEGIN, the global leader in magnetoencephalography (MEG), to make high-precision brain scans widely accessible. The partnership will introduce consumer-friendly MEG brain scans, starting with MYndspan’s flagship location in London later this year.

MEG is a gold-standard technology for assessing brain function, capturing real-time neural activity with unmatched accuracy. Traditionally limited to hospitals and research institutions, MEG directly measures magnetic fields generated by neurons, offering an immediate and detailed view of brain activity. This collaboration marks a major step in bringing clinical-grade brain function analysis to the public.

“The future of brain health lies in tracking and understanding brain activity,” said Caitlin Baltzer, Co-Founder and CEO of MYndspan. “By working with MEGIN, we’re making MEG technology accessible outside of clinical settings, empowering individuals with precise brain health insights.”

For over 30 years, MEGIN has led the MEG market, with over 120 systems installed worldwide, including at Oxford, Cambridge, and MIT. The technology is used in cognitive research, epilepsy studies, and biomarker detection for neurodegenerative diseases.

“This partnership represents a significant step in making MEG more accessible,” said Craig Shapero, CEO of MEGIN. “Together with MYndspan, we’re bridging the gap between cutting-edge neuroimaging and consumer brain health.”

MYndspan’s brain scans analyze functional brain age, stability, and localized neural activity, detecting early signs of neurodegenerative changes. The London brain health center will provide individuals with direct access to MEG-powered insights, supporting proactive cognitive well-being.